Note: Ingredients listed on restricted chemical lists
EC/CAS
205-302-8/137-58-6
Name of the chemical
Lidocaine (INN)
Concentration
5.0%
EC/CAS
232-554-6/9000-70-8
Name of the chemical
gelatin
Concentration
Proprietary
EC/CAS
200-289-5/56-81-5
Name of the chemical
glycerol
Concentration
Proprietary
EC/CAS
310-194-1/1332-58-7
Name of the chemical
kaolin
Concentration
Proprietary
EC/CAS
202-785-7/99-76-3
Name of the chemical
4-hydroxybenzoic acid, methyl ester
Concentration
Proprietary
EC/CAS
200-338-0/57-55-6
Name of the chemical
1,2-propanediol
Concentration
Proprietary
EC/CAS
202-307-7/94-13-3
Name of the chemical
Propylparaben; propyl 4-hydroxybenzoate
Concentration
Proprietary
EC/CAS
200-061-5/50-70-4
Name of the chemical
D-glucitol C6H14O6
Concentration
Proprietary
EC/CAS
201-766-0/87-69-4
Name of the chemical
L-(+)-tartaric acid
Concentration
Proprietary
EC/CAS
200-315-5/57-13-6
Name of the chemical
urea
Concentration
Proprietary
EC/CAS
231-791-2/7732-18-5
Name of the chemical
Water, distilled, conductivity or of similar purity H2O
Concentration
Proprietary
General Information
Revision date
2015-08-03
Product name
LIDOCAINE TOPICAL 5% PATCH
Product Synonyms
FORMULA (for active ingredient): C14H22N2O
Chemical name
For
1.2.2. Uses advised against
Non-Pharmaceutical Use
supplier name
U.S
Emergency telephone
1-800-424-9300, +1-703-527-3887
Icons in SDS
Company Information
company name
ACTAVIS, INC
e-mail address of the competent person responsible for the Safety Data Sheet
SDS@Actavis.com
Section 2
SECTION 2: Hazards identification
Product definition
This product consists is comprised of an adhesive material containing 5% Lidocaine in an aqueous base, which is applied to a non-woven polyester felt backing and covered with a polyethylene terephthalate (PET) film release liner, and is packaged in a foil-backed pouch.
Health hazards
The chief health hazard associated with exposure during normal use and handling is the potential for irritation of contaminated skin. Prolonged skin contact may cause symptoms of therapeutic use. In therapeutic use, the most common adverse effects reported are mild irritation, redness, or swelling where the medication is applied; or numbness in places patch is supplied. Adverse effects on the central nervous and cardiovascular system have been reported. Persons who are allergic to amide-type local anesthetics such as Lidocaine, may experience allergic reactions to this product. Severe allergic reactions can occur and can include anaphylactic reactions and shock. More information on adverse effects from therapeutic use is described in Section 11 (Toxicological Information). Reactivity Hazards: This product is not reactive. Flammability Hazards: This product may be combustible and may ignite if involved in a fire and the water evaporates. When involved in a fire, this material may decompose and produce irritating vapors and toxic compounds (including carbon and nitrogen oxides, acrolein).
Environmental hazards
Large quantities released to the aquatic and terrestrial environment may have an adverse effect. Emergency Considerations: Emergency responders should wear appropriate protection for situation to which they respond.